Brief: AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan
16/08/2024 12:03
Aug 16 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS ADOPTS LIMITED DURATION STOCKHOLDER
RIGHTS PLAN
* AN2 THERAPEUTICS INC - ADOPTED LIMITED DURATION
STOCKHOLDER
RIGHTS PLAN, WHICH IS SCHEDULED TO EXPIRE ON AUGUST 15, 2025
Source text for Eikon: ID:nBw4wvyRMa
Further company coverage: ANTX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview